Group 1 - The eighth China International Import Expo (CIIE) is set to open, with Novartis participating for the eighth consecutive time, emphasizing its commitment to being a valuable and trustworthy healthcare partner in China [1][2] - Novartis will showcase nearly 20 innovative products across four core therapeutic areas: cardiovascular, renal and metabolic, oncology, and neuroscience, highlighting its strong innovation capabilities [1] - The "Focus on Innovation" exhibition area will feature award-winning products and immersive experiences, allowing attendees to engage with cutting-edge drug mechanisms and treatment methods [1] Group 2 - Novartis aims to deepen its roots in China, reflecting on its century-long history in the country and its new vision for development since 2018, which includes increased investment and collaboration with local industries [2] - The "Access to Medicine" exhibition area will demonstrate Novartis's efforts to enhance medicine accessibility for Chinese patients through partnerships with government, hospitals, and industry players [2] - A giant curved screen at the Novartis booth will showcase advanced pharmaceutical technologies, while an employer culture experience area will allow visitors to engage with the company's culture and receive commemorative badges [2]

Core Insights - Novartis will participate in the 8th China International Import Expo, marking its eighth consecutive appearance, emphasizing its commitment to becoming China's most valuable and trusted healthcare partner [1][2] Group 1: Innovation Focus - The "Focus on Innovation" exhibition area will showcase nearly 20 innovative products across four core therapeutic areas: cardiovascular, renal and metabolic, oncology, immunology, and neuroscience [1] - Attendees will have the opportunity to experience award-winning products and new indications for blockbuster drugs, including targeted therapies for cancer and innovative renal treatment pipelines [1] - An immersive interactive experience using advanced spatial computing display technology will allow visitors to explore the journey of innovative drugs within the human body [1] Group 2: Commitment to China - The "Deepening in China" exhibition area will reflect Novartis's century-long relationship with China and its new vision for development in the country [2] - Since 2018, Novartis has aligned its growth strategy with the Import Expo, increasing investments and fostering trust within the industry to contribute sustainably to China's innovative pharmaceutical ecosystem [2] Group 3: Accessibility of Medicine - The "Pharmaceutical Accessibility" exhibition area will highlight Novartis's efforts to enhance medicine accessibility for Chinese patients [2] - The area will showcase collaborations with partners in the pharmaceutical ecosystem, focusing on integrating innovative drugs into the national medical insurance directory and exploring diverse solutions for improving medicine accessibility [2] - A giant curved screen at the exhibition will inspire attendees to envision the future of healthcare through advanced pharmaceutical technologies [2]